In a January 2013 Press Release, TNI BioTech was given exclusive rights to patent and formulate LDN for pediatric Crohn's disease. This is the first step in widespread approval for LDN.
Elaine-Moore.com | Elaine Moore Graves' Disease and Autoimmune Disease Education Copyrighted by Elaine Moore © 2008-2020 All Rights Reserved. All writing and images copyrighted. Copyright Notices and Disclaimer